| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8659806 | Heart, Lung and Circulation | 2018 | 4 Pages |
Abstract
Apixaban and VKA therapy were associated with a similar impact on the composite endpoint in real-world German practice. Additional investigation is needed to evaluate the numeric trends of ischaemic stroke and decreased number of MIs observed with apixaban, as well as the high rate of reduced dose apixaban use found in this analysis.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Craig I. PharmD, W. Frank MD, Matthias MD,